These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6311767)

  • 41. Properties of "enkephalinase" from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities.
    Malfroy B; Schwartz JC
    Biochem Biophys Res Commun; 1982 May; 106(2):276-85. PubMed ID: 7049171
    [No Abstract]   [Full Text] [Related]  

  • 42. Enkephalinase activity in both physiological and pathological conditions in man.
    Grazia SM
    Adv Exp Med Biol; 1986; 198 Pt B():161-7. PubMed ID: 3544724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitors of calf-brain enkephalinase A and B.
    van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W
    Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propioxatins A and B, new enkephalinase B inhibitors. I. Taxonomy, fermentation, isolation and biological properties.
    Inaoka Y; Tamaoki H; Takahashi S; Enokita R; Okazaki T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1368-77. PubMed ID: 3536826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple molecular forms of rat brain enkephalinase.
    Rush RS; Hersh LB
    Life Sci; 1982 Aug; 31(5):445-51. PubMed ID: 6813615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptides: influence of acute and chronic effects of opiates.
    Krivoy WA; Kroeger DC; Zimmermann E
    Psychoneuroendocrinology; 1977; 2(1):43-51. PubMed ID: 198832
    [No Abstract]   [Full Text] [Related]  

  • 47. [Enzymes for opioid peptide processing and methods of determining their activity].
    Gengin MT; Vernigora AN
    Ukr Biokhim Zh (1978); 1994; 66(2):3-17. PubMed ID: 7998336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory potency of various peptides on enkephalinase activity from mouse striatum.
    Fournie-Zaluski MC; Perdrisot R; Gacel G; Swerts JP; Roques BP; Schwartz JC
    Biochem Biophys Res Commun; 1979 Nov; 91(1):130-5. PubMed ID: 518615
    [No Abstract]   [Full Text] [Related]  

  • 49. Novel agents affecting enkephalinergic and histaminergic transmissions in brain.
    Schwartz JC; Giros B; Gros C; Llorens-Cortes C; Arrang JM; Garbarg M; Pollard H
    Cephalalgia; 1987; 7 Suppl 6():32-5. PubMed ID: 2894899
    [No Abstract]   [Full Text] [Related]  

  • 50. Enkephalinase regulation.
    Ramírez-Sánchez M; Prieto I; Segarra AB; Martínez-Cañamero M; Banegas I; de Gasparo M
    Vitam Horm; 2019; 111():105-129. PubMed ID: 31421697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice.
    Blum K; Briggs AH; Trachtenberg MC; Delallo L; Wallace JE
    Alcohol; 1987; 4(6):449-56. PubMed ID: 2829941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and structure of prolinal-containing peptides, and their use as specific inhibitors of prolyl endopeptidases.
    Nishikata M; Yokosawa H; Ishii S
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2931-6. PubMed ID: 3533287
    [No Abstract]   [Full Text] [Related]  

  • 53. Propioxatins A and B, new enkephalinase B inhibitors. II. Structural elucidation.
    Inaoka Y; Takahashi S; Kinoshita T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1378-81. PubMed ID: 3781907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine kinases and synaptic transmission.
    Boxall AR; Lancaster B
    Eur J Neurosci; 1998 Jan; 10(1):2-7. PubMed ID: 9753108
    [No Abstract]   [Full Text] [Related]  

  • 55. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Zimmer VC; Hartmann T
    Front Aging Neurosci; 2013 Dec; 5():98. PubMed ID: 24391587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children.
    Faure C
    Int J Pediatr; 2013; 2013():612403. PubMed ID: 23533446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.
    Morelli L; Llovera R; Ibendahl S; Castaño EM
    Neurochem Res; 2002 Nov; 27(11):1387-99. PubMed ID: 12512943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Enkephalinase", a newly characterised dipeptidyl carboxypeptidase: properties and possible role in enkephalinergic transmission.
    Schwartz JC; de la Baume S; Malfroy B; Patey G; Perdrisot R; Swerts JP; Fournie-Zaluski MC; Gacel G; Roques BP
    Int J Neurol; 1980; 14(2-4):195-204. PubMed ID: 6311767
    [No Abstract]   [Full Text] [Related]  

  • 60. Properties variations and possible synaptic functions of "enkephalinase": a newly characterised dipeptidyl carboxypeptidase.
    Schwartz JC; de la Baume S; Malfroy B; Patey G; Perdrisot R; Swerts JP; Fournié-Zaluski MC; Gacel G; Roques BP
    Adv Biochem Psychopharmacol; 1980; 22():219-35. PubMed ID: 6994438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.